Evidence-based primary care treatment guidelines for skin infections in Europe: A comparative analysis

European Journal of General Practice

Volumn 20, Issue 4, 2014, Pages 294-300

  Van Bijnen, Evelien M E ^a   Paget, John ^a,b   Den Heijer, Casper D J ^c   Stobberingh, Ellen E ^c   Bruggeman, Cathrien A ^c   Schellevis, François G ^a,d  

^a NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dermatology; Infectious diseases; Quality of care; Treatment

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CLARITHROMYCIN; CLAVULANIC ACID; CLOXACILLIN; FLUCLOXACILLIN; FUSIDIC ACID; PENICILLIN DERIVATIVE; PENICILLIN V; PSEUDOMONIC ACID; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ATTITUDE TO HEALTH; AUSTRIA; AWARENESS; BELGIUM; CELLULITIS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROATIA; ERYSIPELAS; EVIDENCE BASED PRACTICE; FOLLICULITIS; FRANCE; FURUNCULOSIS; HUMAN; HUNGARY; IMPETIGO; NETHERLANDS; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; SPAIN; SWEDEN; SYSTEMATIC REVIEW (TOPIC); THERAPY EFFECT; TREATMENT DURATION; TREATMENT INDICATION; UNITED KINGDOM; WORLD HEALTH ORGANIZATION; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; EUROPE; HEALTH CARE QUALITY; MULTICENTER STUDY; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; SKIN DISEASES, BACTERIAL; STANDARDS;

ANTI-BACTERIAL AGENTS; EUROPE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL;

EID: 84910622800     PISSN: 13814788     EISSN: 17511402     Source Type: Journal    
DOI: 10.3109/13814788.2013.872621     Document Type: Article

References (31)

1. Muller A, Coenen S, Monnet DL, Goossens H. ESAC Project Group. European surveillance of antimicrobial consumption (ESAC): Outpatient antibiotic use in Europe, 1998-2005. Euro Surveill. 2007;12:10.
2. Goossens H, Ferech M, Vander Stichele SR, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005;365:579-87.
3. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-Analysis. Br Med J. 2010;340:c2096.
4. European Commission. Staff working paper of the services of the Commission on antimicrobial resistance. Available at http://ec.europa.eu/food/food/biosafety/salmonella/antimicrobial- resistance.pdf (accessed June 2013).
5. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003; 36:1433-7.
6. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-Acquired meticillin-resistant Staphylococcus aureus: An emerging threat. Lancet Infect Dis. 2005; 5: 275-86.
7. Carrie AG, Zhanel GG. Antibacterial use in community practice: Assessing quantity, indications and appropriateness, and relationship to the development of antibacterial resistance. Drugs 1999;57:871-81.
8. Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-53.
9. Beardsley JR, Williamson JC, Johnson JW, Ohl CA, Karchmer TB, Bowton DL. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-Acquired pneumonia. Chest 2006;130:787-93.
10. Infectious Diseases Society of America (IDSA). Combating antimicrobial resistance: Policy recommendations to save lives. Clin Infect Dis. 2011;52:S397-S428.
11. Den Heijer CDJ, Donker GA, Maes J, Stobberingh EE. Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: A comparison of two surveys with a 5 year interval. J Antimicrob Chemother. 2010;65:2128-33.
12. Burgers JS, Bailey JV, Klazinga NS, Van Der Bij AK, Grol R, Feder G, et al. Inside Guidelines: Comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 2002: 25: 1933-9.
13. Lugtenberg M, Burgers JS, Westert GP. Effects of evidence-based clinical practice guidelines on quality of care: A systematic review. Qual Saf Health Care 2009;18:385-92.
14. Burgers JS, Grol R, Klazinga NS, Mäkelä M, Zaat J, AGREE Collaboration. Towards evidence-based clinical practice: An international survey of 18 clinical guideline programs. Int J Qual Health Care 2003;15:31-45.
15. Lamy JB, Ebrahiminia V, Riou C, Seroussi B, Bouaud J, Simon C, et al. How to translate therapeutic recommendations in clinical practice guidelines into rules for critiquing physician prescriptions? Methods and application to five guidelines. BMC Med Inform Decis Mak. 2010;10:31-44.
16. Grol R, van Weel C. Getting a grip on guidelines: How to make them more relevant for practice. Br J Gen Pract. 2009;59:e143-e144.
17. Rautakorpi UM, Huikko S, Honkanen P, Klaukka T, Mäkelä M, Palva E, et al. The antimicrobial treatment strategies (MIKSTRA) program: A 5-year follow-up of infection-specific antibiotic use in primary health care and the Effect of implementation of treatment guidelines. Clin Infect Dis. 2006;42:1221-30.
18. Petersen I, Hayward AC. Antibacterial prescribing in primary care. J. Antimicrob. Chemother. 2007;60(Suppl.):i43-i47.
19. Ray GT, Suaya JA, Baxter R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: A retrospective population-based study. BMC Infect Dis. 2013, 13:252-62.
20. Miller LG, Kaplan SL. Staphylococcus aureus: A community pathogen. Infect Dis Clin North Am. 2009;23:35-52.
21. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. GRADE: going from evidence to recommendations. Br Med J. 2008;336:1049-51.
22. Ebell MH, Siwek J, Weiss B, Woolf SH, Susman J, Ewigman B, et al. Strength of recommendation taxonomy (SORT): A patient-centered approach to grading evidence in the medical literature. Am Fam Physician 2004;69:548-56.
23. Van Bijnen EME, den Heijer CDJ, Paget WJ, Stobberingh EE, Verheij RA, Bruggeman CA, et al. The appropriateness of prescribing antibiotics in the community in Europe: Study design. BMC Infect Dis. 2011;11:293.
24. Bernard P. Management of common bacterial infections of the skin. Curr Opin Infect Dis. 2008;21:122-8.
25. Stulberg DL, Penrod MA, Blatny RA. Common bacterial skin infections. Am Fam Physician 2002;66:119-25.
26. Pangilinan R, Tice A, Tillotson G. Topical antibiotic treatment for uncomplicated skin and skin structure infections: Review of the literature. Expert Rev Anti Infect Ther. 2009;7:957-65.
27. DDD Classification. http://www.whocc.no/atc-ddd-index (accessed June 2013).
28. El Moussaoui R, De Borgie CAJM, Van den Broek P, Hustinx WN, Bresser P, Van den Berk GEL, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: Randomised, double blind study. Br Med J. 2006;332:1355-61.
29. Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European surveillance of antimicrobial consumption (ESAC): Outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother. 2011;66(Suppl.):vi3-12.
30. Grol R, Wensing M. What drives change? Barriers to and incentives for achieving evidence-based practice. Med J Aust. 2004;180(Suppl.):S57-60.
31. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJC, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373-406.